Article Information
History
- June 24, 2020.
Article Versions
- You are currently viewing Version 1 of this article (June 24, 2020 - 07:09).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Qiang Su, MDa,
- Jie-xuan Hu, MDa,
- Hai-shan Lin, MDa,
- Zheng Zhang, MDb,
- Emily C. Zhu, PhDc,
- Chen-guang Zhang, PhDd,*,
- Di-ya Wang, PhDe,*,
- Zu-hua Gao, MDf,* and
- Bang-wei Cao, MDa,*
- aDepartment of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China
- bDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China
- cMcCoy College of Business, Texas State University, 601 University Dr., San Marcos, Texas 78666, USA
- dDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China
- eDepartment of Radiation Oncology, University of California, San Francisco, CA, USA
- fDepartment of Pathology, Research Institute of McGill University Health Center, Montreal, QC, Canada
- ↵*Correspondence authors E-mail address: chzhang{at}ccmu.edu.cn for Dr Chenguang Zhang; wang.diya{at}hotmail.com for Dr Di-ya Wang; Zu-hua.gao{at}mcgill.ca for Dr Zu-hua Gao; oncology{at}ccmu.edu.cn for Dr Bang-wei Cao
Posted June 24, 2020.
Prevalence and risks of severe events for cancer patients with COVID-19 infection: a systematic review and meta-analysis
